维普中文期刊产品整合服务
47篇 您的检索式:作者名="JONES SF"
    题名 作者 年代 出处 被引量
1A drug interaction studyevaluating the pharmacokinetics and toxicity of sorafenib in combina-tion with capecitabine 显示文摘Infante JR Jones SF Bendell JC 2012Cancer Chemother Pharmacol2012,69,:1
2Obesity is a risk factor for dyspnea but not for airflow obstruction显示文摘Sin DD Jones RL Man SF 0,,:1
3The bode index predicts survival after lung transplantation for chronic obstructive pulmonary disease显示文摘Reid JS Jones SF Dransfield MT 2006Chest Meeting Abstracts2006,130,4:1
4A phase 1 and pharmaeoki- netic study of oral lapatinib administered once or twice daily in patients with solid malignancies 显示文摘Burris HA 3rd Taylor CW Jones SF 2009Clin Cancer Res2009,15,21:1
5A phase I trial of oral administration of panobinostat in combination with pa- clitaxel and carhoplatin in patients with solid tumors显示文摘Jones SF Infante JR Thompson DS 2012Cancer Chemother Pharmacol2012,70,3:1
6Nebulized morphine for relief of dyspnea due to chronic lung disease显示文摘Brown SJ Eichner SF Jones JR 2005Ann Pharmacother2005,39,6:1
7Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer显示文摘Burris HA Jones SF Shipley D 2010Cancer Invest2010,28,4:1
8Positron emission tomography imaging in dementia显示文摘Herholz K Carter SF Jones M 2007Br J Radiol2007,80,2:1
9Phase Ib evaluation of MPDL3280A ( anti - PDLl ) in combination with bevacizumab (bev) in patients ( pts) with metastatic renal cell carcinoma (mRCC)显示文摘Sznol M Mcdermott DF Jones SF 2015J Clin Oncol2015,33,7:1
10Simple nutritional indicators as independent predictors of mortality in hemodialysis patients显示文摘Leavey SF Strawderman RL Jones CA 1998Am J Kidney Dis1998,31,6:1
11Phase I, open- label, multicentre, dose-esealation, pharmaeokinetie and pharmacodynamie trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours显示文摘SCHOFFSKI P JONES SF DUMEZ H 2011Eur J Cancer2011,47,15:1
12ICU delirium: an update显示文摘Jones SF Pisani MA 2012Curr Opin Crit Care2012,18,2:1
13Simple nutritional di- alysis indicators as independent predictors of mortality in hemodialysis patients 显示文摘Leavey SF Strawderman RL Jones CA 1998Am J Kidney Dis1998,31,6:1
14Vinorelbine:a new antineoplastic drug for the treatment of non-small-cell lung cancer显示文摘Jones SF Burris HA 1996Ann Pharmacother1996,30,5:1
15Vinorelbine:a new antineoplastic drug for the treatment of non-small-cell lung cancer显示文摘Jones SF burris HA 1996Ann Pharmacother1996,30,5:1
16Medullary sponge kid- ney and urinary calculi: aeromedical concerns 显示文摘Jones JA Cherian SF Barr YR 2008Aviat Space Environ Med2008,79,7:1
17The bode index predicts survival after lung transplantation for chronic obstructive pulmonary disease 显示文摘Reid JS Jones SF Dransfield MT 2006Chest Meeting Abstracts2006,130,4:1
18Vinorelbine:a new antineoplastic drug for the treatment of non-small cell lung cancer显示文摘Jones SF Burris HA 1996Ann Pharmacother1996,30,5:1
19Morphine and Ibupr of encomparedusing the cold pressortest显示文摘Jones SF 1988Pain1988,,34:1
20Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer 显示文摘Jones SF Bun'is HA 3rd 1996Ann Pharmacother1996,30,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费